{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:00:00Z","timestamp":1785214800614,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Primary malignant melanoma of the esophagus (PMME) is a rare malignancy of the esophagus. The main treatment is esophagectomy, but the recurrence and metastasis rate are very high, and the prognosis is very poor. Here, we report a case of locally advanced PMME that rapidly developed intracranial metastases after surgery and adjuvant therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>The patient was a 47-year-old male with dysphagia. Endoscopy revealed multiple cauliflower-like lesions in the middle esophagus, confirmed as malignant melanoma via biopsy with positive immunohistochemical staining for SOX-10 and Melan-A, with regional lymph node metastases. The patient was diagnosed with PMME and was treated with radical esophagectomy. The adjuvant therapy used tislelizumab combined with lenvatinib. Five months after surgery, follow-up magnetic resonance imaging (MRI) indicated multiple intracranial metastases. The patient underwent a tumor resection of the left cerebellar lesion, and stereotactic radiosurgery for other lesions, and received oral temozolomide. One month after radiotherapy, his condition deteriorated rapidly, showing systemic progression, and he eventually passed away ten months after diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite surgical resection and adjuvant therapy, this case of PMME rapidly progressed with multiple intracranial metastases, highlighting the highly aggressive nature and poor prognosis of this malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1880200","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:10Z","timestamp":1785212710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Locally advanced primary esophageal melanoma with early brain metastasis"],"prefix":"10.3389","volume":"16","author":[{"given":"Huixin","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Cancer Center, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cancer Center, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cancer Center, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunjie","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Cancer Center, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Cancer Center, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cancer Center, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cancer Center, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cancer Center, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e318216b99b","article-title":"Primary Malignant melanoma of the esophagus: a clinicopathologic study of a case with comprehensive literature review","volume":"18","author":"Bisceglia","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153725","article-title":"The thousand faces of Malignant melanoma: a systematic review of the primary Malignant melanoma of the esophagus","volume":"14","author":"Cazzato","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i11.3296","article-title":"Primary advanced esophago-gastric melanoma: a rare case","volume":"22","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10519","article-title":"Clinicopathological characteristics and survival of primary Malignant melanoma of the esophagus","volume":"18","author":"Hashimoto","year":"2019","journal-title":"Oncol Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2020.03.006","article-title":"Results of surgical treatment for primary Malignant melanoma of the esophagus: a multicenter retrospective study","author":"Dai","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doaf009","article-title":"Characteristics analyses and tumor staging proposal for primary Malignant melanoma of the esophagus: a retrospective study","volume":"38","author":"Ye","year":"2025","journal-title":"Dis Esophagus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13034","article-title":"Primary Malignant melanoma of the esophagus: a retrospective analysis of clinical features, management, and survival of 76 patients","volume":"10","author":"Wang","year":"2019","journal-title":"Thorac Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jtho.2016.10.016","article-title":"Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer","volume":"12","author":"Rice","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21037\/acs.2017.03.14","article-title":"8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice","volume":"6","author":"Rice","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100811","article-title":"Longitudinal genomic alternations and clonal dynamics analysis of primary Malignant melanoma of the esophagus","volume":"30","author":"Li","year":"2022","journal-title":"Neoplasia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0163-y","article-title":"Primary Malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors","volume":"32","author":"Lasota","year":"2019","journal-title":"Mod Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.70097","article-title":"Treatment outcomes of surgery and ICI therapy in 52 patients with esophageal melanoma: a retrospective single-center cohort study","volume":"53","author":"Ishiguro","year":"2026","journal-title":"J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dote.12504","article-title":"Patterns of care and survival outcomes in the treatment of esophageal melanoma","volume":"30","author":"Weiner","year":"2017","journal-title":"Dis Esophagus"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01219","article-title":"Longer follow-up confirms relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600-mutant stage III melanoma","volume":"36","author":"Hauschild","year":"2018","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0739","article-title":"Phase II randomized trial comparing high-dose IFN-\u03b12b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma","volume":"19","author":"Lian","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.9589","article-title":"Phase III randomized, multicenter trial comparing high-dose IFN-a2b with temozolomide plus cisplatin as adjuvant therapy for resected mucosal melanoma","volume":"36","author":"Lian","year":"2018","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.002","article-title":"Toripalimab (anti-PD-1) versus high-dose interferon-\u03b12b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial","volume":"33","author":"Lian","year":"2022","journal-title":"Ann Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70169","article-title":"Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis","volume":"15","author":"Dai","year":"2025","journal-title":"Clin Transl Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00262-023-03593-2","article-title":"Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment","volume":"73","author":"Baginska","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B20","unstructured":"Neoadjuvant pembrolizumab and lenvatinib in resectable mucosal melanoma: NeoPlus study update\n          \n          \n            \n              Mao\n              L\n            \n            \n              Dai\n              J\n            \n            \n              Bai\n              X\n            \n          \n          Journal of Clinical Oncology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-19-2349","article-title":"Treatment and prognosis of primary Malignant melanoma of the esophagus","volume":"9","author":"Cheng","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74056","article-title":"A rare and rapidly progressive case of primary esophageal Malignant melanoma in an elderly patient","volume":"16","author":"Sobrosa","year":"2024","journal-title":"Cureus"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1880200\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:20Z","timestamp":1785212720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1880200\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":22,"alternative-id":["10.3389\/fonc.2026.1880200"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1880200","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1880200"}}